Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
DIPHTHERIA TOXOID TETANUS TOXOID PERTUSSIS TOXOID FILAMENTOUS HAEMAGGLUTININ (FHA) PERTACTIN POLIO VIRUS TYPE 1 INACTIVATED POLIO VIRUS TYPE 2 INACTIVATED POLIO VIRUS TYPE 3 INACTIVATED HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) AND TETANUS TOXOID TETANUS VACCINE ADSORBED
GlaxoSmithKline (Ireland) Limited
2003-04-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Infanrix-IPV+Hib – powder and suspension for suspension for injection Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION A 0.5 ml dose of vaccine contains: Diphtheria toxoid 1 not less than 30 International Units (IU) Tetanus toxoid 1 not less than 40 International Units (IU) _Bordetella pertussis _antigens Pertussis toxoid 1 25 µg Filamentous haemagglutinin 1 25 µg Pertactin 1 8 µg Poliovirus (inactivated) type 1 (Mahoney strain) 2 40 D-antigen unit type 2 (MEF-1 strain) 2 8 D-antigen unit type 3 (Saukett strain) 2 32 D-antigen unit Haemophilus type b polysaccharide (polyribosylribitol phosphate) 10 µg conjugated to tetanus toxoid as carrier protein approximately 30 µg 1 Adsorbed on aluminium hydroxide, hydrated 0.5 milligrams Al 2 Propagated in VERO cells For a full list of excipients, _see section 6.1._ 3 PHARMACEUTICAL FORM Powder and suspension for suspension for injection. The diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis (DTPa-IPV) component is a turbid white suspension. The lyophilised _Haemophilus influenzae _type b (Hib) component is a white powder. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 27/10/2011_ _CRN 2102463_ _page number: 1_ 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS INFANRIX-IPV+Hib is indicated for active immunisation against diphtheria, tetanus, pertussis, poliomyelitis and _Haemophilus influenzae _type b disease from the age of 2 months. INFANRIX-IPV+Hib is not intended for use in children over 36 months of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _POSO Прочетете целия документ